Today's Top Stories | | By The Associated Press | July 11, 2025 05:12 AM |
| | | By The Associated Press | July 10, 2025 11:45 PM |
| | By The Associated Press | July 10, 2025 11:23 PM |
| | By Wyatt Investment Research |
| | By Jeffrey Neal Johnson | July 10, 2025 03:36 PM |
| | By Thomas Hughes | July 10, 2025 03:09 PM |
|
|
Your Watchlist | | - Amazon.com (NASDAQ:AMZN) had its price target raised by analysts at JPMorgan Chase & Co. (
  ) from $240.00 to $255.00. They now have an "overweight" rating on the stock. This represents a 14.4% upside from the current price of $222.89. - insider Jeffrey P. Bezos sold 101,081 shares of Amazon.com stock in a transaction on Tuesday, July 8th. The shares were sold at an average price of $223.88, for a total transaction of $22,630,014.28. Following the completion of the sale, the insider directly owned 902,379,449 shares in the company, valued at approximately $202,024,711,042.12. The trade was a 0.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
- insider Jeffrey P. Bezos sold 384,124 shares of Amazon.com stock in a transaction on Wednesday, July 9th. The shares were sold at an average price of $224.02, for a total transaction of $86,051,458.48. Following the completion of the sale, the insider directly owned 901,995,325 shares in the company, valued at approximately $202,064,992,706.50. The trade was a 0.04% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
- (7/11) Amazon.com (AMZN) Faces Challenges in AI Leadership (insidermonkey.com)
- (7/11) Amazon.com (NASDAQ:AMZN) Price Target Raised to $255.00 at JPMorgan Chase & Co. (marketbeat.com)
- (7/11) Prediction: These 2 No-Brainer Growth Stocks Will Beat the Market in the Next 10 Years (fool.com)
- (7/11) 44th Anniversary Buy-and-Hold Pick: Amazon.com (AMZN) (schaeffersresearch.com)
- (7/11) The Ultimate Growth Stock to Buy With $1,000 Right Now (fool.com)
| | - insider Jennifer Newstead sold 519 shares of the firm's stock in a transaction dated Tuesday, July 8th. The stock was sold at an average price of $721.57, for a total value of $374,494.83. Following the sale, the insider directly owned 27,107 shares of the company's stock, valued at approximately $19,559,597.99. This trade represents a 1.88% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
- (7/11) Meta Notified of Potential Antitrust Violation by French Agency (bloomberg.com)
- (7/11) U.S. Capital Wealth Advisors LLC Grows Stock Holdings in Meta Platforms, Inc. (NASDAQ:META) (marketbeat.com)
- (7/11) Richard Bernstein Advisors LLC Sells 1,949 Shares of Meta Platforms, Inc. (NASDAQ:META) (marketbeat.com)
- (7/11) Meta Platforms, Inc. (META) "Still Has A Low Multiple," Says Jim Cramer (insidermonkey.com)
- (7/11) Should You Forget Nvidia and Buy These 2 Artificial Intelligence (AI) Stocks Right Now? (fool.com)
| |
|
Manage Your Watchlist
|
Analysts' Upgrades | | AMC Entertainment (NYSE:AMC) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $4.00 price target on the stock, up previously from $3.00. This represents a 21.0% upside from the current price of $3.31. | | Astronics (NASDAQ:ATRO) was upgraded by analysts at Truist Financial Corporation from a "hold" rating to a "buy" rating. They now have a $49.00 price target on the stock. This represents a 39.9% upside from the current price of $35.03. | | Cinemark (NYSE:CNK) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $37.00 price target on the stock, up previously from $32.00. This represents a 22.7% upside from the current price of $30.16. | | Corebridge Financial (NYSE:CRBG) was upgraded by analysts at UBS Group AG from a "sell" rating to a "neutral" rating. They now have a $37.00 price target on the stock, up previously from $28.00. This represents a 7.6% upside from the current price of $34.38. | | Danaher (NYSE:DHR) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $275.00 price target on the stock. This represents a 34.2% upside from the current price of $204.98. | | FB Financial (NYSE:FBK) was upgraded by analysts at Keefe, Bruyette & Woods from a "market perform" rating to an "outperform" rating. They now have a $58.00 price target on the stock. This represents a 21.4% upside from the current price of $47.77. | | Canada Goose (NYSE:GOOS) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. They now have a $14.00 price target on the stock, up previously from $11.00. This represents a 0.7% upside from the current price of $13.90. | | GXO Logistics (NYSE:GXO) was upgraded by analysts at Truist Financial Corporation from a "hold" rating to a "buy" rating. They now have a $62.00 price target on the stock, up previously from $48.00. This represents a 20.0% upside from the current price of $51.67. | | Invesco (NYSE:IVZ) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $18.00 price target on the stock, up previously from $14.50. This represents a 3.5% upside from the current price of $17.40. | | SLM (NASDAQ:SLM) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $38.00 price target on the stock, up previously from $29.00. This represents a 13.5% upside from the current price of $33.48. | | TE Connectivity (NYSE:TEL) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $200.00 price target on the stock, up previously from $150.00. This represents a 13.4% upside from the current price of $176.37. | | Thermo Fisher Scientific (NYSE:TMO) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $590.00 price target on the stock. This represents a 36.5% upside from the current price of $432.22. | | Texas Instruments (NASDAQ:TXN) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating. They now have a $245.00 price target on the stock, up previously from $200.00. This represents a 11.7% upside from the current price of $219.36. | | Visteon (NASDAQ:VC) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $125.00 price target on the stock, up previously from $96.00. This represents a 13.1% upside from the current price of $110.56. | | Visteon (NASDAQ:VC) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $120.00 price target on the stock. This represents a 8.5% upside from the current price of $110.56. |
|
View More Upgrades
|
Analysts' Downgrades | | Agree Realty (NYSE:ADC) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $75.00 price target on the stock. This represents a 5.3% upside from the current price of $71.25. | | AerSale (NASDAQ:ASLE) was downgraded by analysts at Truist Financial Corporation from a "buy" rating to a "hold" rating. They now have a $6.00 price target on the stock, down previously from $8.00. This represents a 2.5% upside from the current price of $5.86. | | Boyd Gaming (NYSE:BYD) was downgraded by analysts at Susquehanna from a "positive" rating to a "neutral" rating. They now have a $86.00 price target on the stock, up previously from $76.00. This represents a 8.1% upside from the current price of $79.54. | | Expeditors International of Washington (NASDAQ:EXPD) was downgraded by analysts at Bank of America Corporation from a "neutral" rating to an "underperform" rating. They now have a $118.00 price target on the stock, up previously from $117.00. This represents a 1.3% upside from the current price of $116.46. | | Freeport-McMoRan (NYSE:FCX) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $50.00 price target on the stock, up previously from $45.00. This represents a 8.5% upside from the current price of $46.09. | | FrontView REIT (NYSE:FVR) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $13.50 price target on the stock. This represents a 12.2% upside from the current price of $12.03. | | Hancock Whitney (NASDAQ:HWC) was downgraded by analysts at Keefe, Bruyette & Woods from an "outperform" rating to a "market perform" rating. They now have a $63.00 price target on the stock. This represents a 4.1% upside from the current price of $60.50. | | Illumina (NASDAQ:ILMN) was downgraded by analysts at Scotiabank from a "sector outperform" rating to a "sector perform" rating. They now have a $125.00 price target on the stock. This represents a 24.9% upside from the current price of $100.10. | | Mid-America Apartment Communities (NYSE:MAA) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $165.00 price target on the stock. This represents a 9.2% upside from the current price of $151.16. | | North American Construction Group (NYSE:NOA) (TSE:NOA) was downgraded by analysts at Canaccord Genuity Group Inc. from a "buy" rating to a "hold" rating.The current price is $15.82. | | Northern Trust (NASDAQ:NTRS) was downgraded by analysts at Keefe, Bruyette & Woods from a "market perform" rating to an "underperform" rating. They now have a $120.00 price target on the stock. This represents a 3.8% downside from the current price of $124.76. | | Oscar Health (NYSE:OSCR) was downgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "underweight" rating. They now have a $10.00 price target on the stock, down previously from $16.00. This represents a 31.5% downside from the current price of $14.59. | | Energy Fuels (NYSEAMERICAN:UUUU) was downgraded by analysts at Roth Capital from a "buy" rating to a "neutral" rating. They now have a $6.00 price target on the stock. This represents a 3.4% downside from the current price of $6.21. |
|
View More Downgrades
|
 | Recession Fears Mounting? 2 AI Stocks to Watch Now (ad)2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines.
But even in uncertain times, innovation doesn't slow down.
In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles.
Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they're still flying below most investors' radar.
👉[Click here to access your FREE AI stocks report now.] |
|
Analysts' New Coverage | | Circle Internet Group (NYSE:CRCL) is now covered by analysts at Robert W. Baird. They set a "neutral" rating and a $210.00 price target on the stock. This represents a 7.9% upside from the current price of $194.60. | | CoreWeave (NASDAQ:CRWV) is now covered by analysts at Argus. They set a "buy" rating and a $200.00 price target on the stock. This represents a 52.8% upside from the current price of $130.88. | | Harrow (NASDAQ:HROW) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $76.00 price target on the stock. This represents a 122.9% upside from the current price of $34.09. | | Innoviva (NASDAQ:INVA) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $26.00 price target on the stock. This represents a 37.2% upside from the current price of $18.95. | | Janux Therapeutics (NASDAQ:JANX) is now covered by analysts at Raymond James Financial, Inc.. They set an "outperform" rating and a $65.00 price target on the stock. This represents a 155.4% upside from the current price of $25.46. | | James Hardie Industries (NYSE:JHX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $32.00 price target on the stock. This represents a 16.6% upside from the current price of $27.45. | | KALA BIO (NASDAQ:KALA) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $12.00 price target on the stock. This represents a 84.3% upside from the current price of $6.51. | | Karyopharm Therapeutics (NASDAQ:KPTI) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $27.00 price target on the stock. This represents a 552.8% upside from the current price of $4.14. | | Centrus Energy (NYSE:LEU) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $220.00 price target on the stock. This represents a 7.5% upside from the current price of $204.61. | | OMS Energy Technologies (NASDAQ:OMSE) is now covered by analysts at Roth Capital. They set a "buy" rating and a $10.00 price target on the stock. This represents a 44.9% upside from the current price of $6.90. | | Ring Energy (NYSEAMERICAN:REI) is now covered by analysts at Alliance Global Partners. They set a "buy" rating and a $2.50 price target on the stock. This represents a 215.7% upside from the current price of $0.79. | | Standard Lithium (NYSEAMERICAN:SLI) is now covered by analysts at Raymond James Financial, Inc.. They set an "outperform" rating and a $2.75 price target on the stock. This represents a 2.8% downside from the current price of $2.83. | | SoFi Technologies (NASDAQ:SOFI) is now covered by analysts at TD Cowen. They set a "hold" rating and a $21.00 price target on the stock. This represents a 3.3% downside from the current price of $21.72. | | Taysha Gene Therapies (NASDAQ:TSHA) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $8.00 price target on the stock. This represents a 204.9% upside from the current price of $2.62. | | Tvardi Therapeutics (NASDAQ:TVRD) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $52.00 price target on the stock. This represents a 122.3% upside from the current price of $23.39. | | Vir Biotechnology (NASDAQ:VIR) is now covered by analysts at Raymond James Financial, Inc.. They set an "outperform" rating and a $12.00 price target on the stock. This represents a 105.0% upside from the current price of $5.86. |
|
View More New Coverage
|
Calendars from MarketBeat | |
|
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| Start Your 30-Day Free Trial |
| Upgrade Your Subscription | Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | | Upgrade Now |
|
| Manage Your Watchlist | View and add up to ten holdings to your watchlist. | | View My Portfolio |
|
| Join Our Facebook Group | Join MarketBeat's free stock discussion and trading idea group on Facebook. | | Join Now |
|
|
Apple Inc. (AAPL)
Amazon.com, Inc. (AMZN)
Alphabet Inc. (GOOGL)
Meta Platforms, Inc. (META)
Microsoft Corporation (MSFT)
0 Response to "🌎 CoreWeave Initiated, Oscar Health Downgraded, SoFi Technologies Initiated and more..."
Post a Comment